Poet seems a phase 3 drug biopharma Company.

Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Reply New Message

Prev Message Back To Forum Threaded View Next Message

sonum

Rank: Treasurer [?]

Points: 1028 [?]

Votes: 111 Score: 1.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Poet seems a phase 3 drug biopharma Company.

posted on Mar 21, 2016 03:50PM

There are a lot of good examples that describe what happen when a company announce good results on phase 3 drug trial.

Patient and confidence in Poet options. High risk but large profits for our `DRUGS`.